戻る Agenda
Session 1, Part 2: Panel Discussion - Stakeholders Experience Regarding Reliance Procedures
Session Chair(s)
Paul Dearden
Senior Director, Global Regulatory Policy
Biogen, United Kingdom
Panel Discussion: Stakeholders Experience Regarding Reliance Procedures
Speaker(s)
Bandar Al Hammad, MPharm
Saudi Food and Drug Authority (SFDA), Saudi Arabia
Chief Pharmacist, Regulatory Affairs Department
Ghadeer Al-Sheikh Salem
Jordan Food and Drug Administration, Jordan
Head, Originator and Biological Drugs Division, Registration Department
Inas Chehimi
Novartis Pharma Services AG, United Arab Emirates
Head RA Middle East & North Africa
Hajed M.H Hashan
Gulf Health Council, Saudi Arabia
Deputy of General Director
Stuart Russel Walker, PhD
Centre for Innovation In Regulatory Science (CIRS), United Kingdom
Professor and Consultant
Rasha Ziada
Egyptian Ministry of Health and Population, Egypt
Chairperson of the Central Adminstration of Pharmaceutical Affairs (CAPA)